OBJECTIVE: Radiotherapy is an invaluable component of head and neck cancer therapy. One of the dreaded complications is osteoradionecrosis, where there is irreversible bone damage and loss in the maxilla or mandible. Although with newer modalities of radiotherapy delivery, the incidence of osteoradionecrosis remains low, it is still a clinically significant problem. This session will cover the etiology and pathogenesis of osteoradionecrosis, along with the diagnosis, management and newer aspects of this clinically challenging entity that dentists and doctors are likely to encounter.
WHAT WILL YOU LEARN IN THIS SESSION?
DATE : 19Th March 2023 | 11 am IST
This Webinar Exclusive for Dentist Channel Online Prime Members
Are you a dentist looking for ways to stay up to date on the latest developments in the industry? Our online Prime Membership is the perfect solution! With our exclusive webinars, you'll have access to a variety of webinars, each containing 1 CE point Certificate (FDA Germany). Plus, Most of the webinars are recorded and available for viewing at any time during your 365-day membership period. Don't miss this opportunity to stay ahead of the curve and get your CE points!
You must log in to post a comment.Log in